These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 21858685

  • 1. Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
    Kou JF, Qian C, Wang JQ, Chen X, Wang LL, Chao H, Ji LN.
    J Biol Inorg Chem; 2012 Jan; 17(1):81-96. PubMed ID: 21858685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.
    Qian C, Wu J, Ji L, Chao H.
    Dalton Trans; 2016 Jun 28; 45(26):10546-55. PubMed ID: 27226117
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
    Putta VR, Chintakuntla N, Mallepally RR, Avudoddi S, K N, Nancherla D, V V N Y, R S P, Surya SS, Sirasani S.
    J Fluoresc; 2016 Jan 28; 26(1):225-40. PubMed ID: 26555289
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
    Zhuo ST, Li CY, Hu MH, Chen SB, Yao PF, Huang SL, Ou TM, Tan JH, An LK, Li D, Gu LQ, Huang ZS.
    Org Biomol Chem; 2013 Jun 28; 11(24):3989-4005. PubMed ID: 23657605
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.
    Du KJ, Wang JQ, Kou JF, Li GY, Wang LL, Chao H, Ji LN.
    Eur J Med Chem; 2011 Apr 28; 46(4):1056-65. PubMed ID: 21295892
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S, Da Settimo F, Taliani S, Simorini F, La Motta C, Fornaciari G, Marini AM.
    Curr Med Chem; 2010 Apr 28; 17(35):4270-90. PubMed ID: 20939813
    [Abstract] [Full Text] [Related]

  • 10. Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes.
    Gao F, Chao H, Wang JQ, Yuan YX, Sun B, Wei YF, Peng B, Ji LN.
    J Biol Inorg Chem; 2007 Sep 28; 12(7):1015-27. PubMed ID: 17659367
    [Abstract] [Full Text] [Related]

  • 11. Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.
    Du K, Liang J, Wang Y, Kou J, Qian C, Ji L, Chao H.
    Dalton Trans; 2014 Dec 14; 43(46):17303-16. PubMed ID: 25315107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity.
    Nunhart P, Konkoľová E, Janovec L, Jendželovský R, Vargová J, Ševc J, Matejová M, Miltáková B, Fedoročko P, Kozurkova M.
    Bioorg Chem; 2020 Jan 14; 94():103393. PubMed ID: 31679839
    [Abstract] [Full Text] [Related]

  • 14. Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
    Zhang P, Wang J, Huang H, Qiao L, Ji L, Chao H.
    Dalton Trans; 2013 Jun 28; 42(24):8907-17. PubMed ID: 23661230
    [Abstract] [Full Text] [Related]

  • 15. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.
    Karki R, Jun KY, Kadayat TM, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES.
    Eur J Med Chem; 2016 May 04; 113():228-45. PubMed ID: 26945111
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
    Genès C, Lenglet G, Depauw S, Nhili R, Prado S, David-Cordonnier MH, Michel S, Tillequin F, Porée FH.
    Eur J Med Chem; 2011 Jun 04; 46(6):2117-31. PubMed ID: 21435753
    [Abstract] [Full Text] [Related]

  • 18. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
    Ribeiro GH, Guedes APM, de Oliveira TD, de Correia CRSTB, Colina-Vegas L, Lima MA, Nóbrega JA, Cominetti MR, Rocha FV, Ferreira AG, Castellano EE, Teixeira FR, Batista AA.
    Inorg Chem; 2020 Oct 19; 59(20):15004-15018. PubMed ID: 32997499
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.